Could a simple oil boost brain health in early psychosis?
NCT ID NCT07122531
First seen May 23, 2026 · Last updated Jun 17, 2026 · Updated 4 times
Summary
This study tests whether a medium-chain triglyceride (MCT) oil supplement, which raises ketone levels, can improve metabolism and symptoms in 15 young adults with first-episode psychosis. Participants take the supplement twice daily for 12 weeks alongside their usual antipsychotic medication. The goal is to see if it is safe, tolerable, and helps with blood sugar control and mental health symptoms.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIRST-EPISODE PSYCHOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hotel-Dieu CIUSSS de l'Estrie-CHUS
RECRUITINGSherbrooke, Quebec, J1H 4C4, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.